Effectiveness of Early Intensive Therapy on Beta-Cell Preservation in Type 1 Diabetes

In new-onset type 1 diabetes, hybrid closed-loop control (HCLC) followed by sensor-augmented pump (SAP) therapy did not provide benefit in preserving beta-cell function compared with current standards of care. Diabetes Care Oct 2013